Our findings reveal that the regulatory effect of VHL on chronic inflammation in ccRCC progression is likely mediated, at least in part, via the LCN2-ROS pathway (Figure 9). This evidence concerns the gene LCN2 and nonpapillary renal cell carcinoma.